Publication:
Putative therapeutic impacts of cardiac CTRP9 in ischaemia/reperfusion injury

Simple item page
dc.contributor.coauthorSadat Ebrahimi, S.R.
dc.contributor.coauthorAmini, H.
dc.contributor.coauthorRahbarghazi, R.
dc.contributor.coauthorHabibollahi, P.
dc.contributor.coauthorGhaderi, S.
dc.contributor.coauthorRezabakhsh, A.
dc.contributor.departmentKUTTAM (Koç University Research Center for Translational Medicine)
dc.contributor.departmentGraduate School of Health Sciences
dc.contributor.kuauthorRajabi, Hadi
dc.contributor.schoolcollegeinstituteGRADUATE SCHOOL OF HEALTH SCIENCES
dc.contributor.schoolcollegeinstituteResearch Center
dc.date.accessioned2024-11-09T13:56:09Z
dc.date.issued2022
dc.description.abstractRecently, cytokines belonging to C1q/tumour necrosis factor-related proteins (CTRPs) superfamily have attracted increasing attention due to multiple metabolic functions and desirable anti-inflammatory effects. These various molecular effectors exhibit key roles upon the onset of cardiovascular diseases, making them novel adipo/cardiokines. This review article aimed to highlight recent findings correlated with therapeutic effects and additional mechanisms specific to the CTRP9, particularly in cardiac ischaemia/reperfusion injury (IRI). Besides, the network of the CTPR9 signalling pathway and its possible relationship with IRI were discussed. Together, the discovery of all involved underlying mechanisms could shed light to alleviate the pathological sequelae after the occurrence of IRI.
dc.description.fulltextYES
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue11
dc.description.openaccessYES
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.sponsorshipN/A
dc.description.versionPublisher version
dc.description.volume26
dc.identifier.doi10.1111/jcmm.17355
dc.identifier.eissn1582-4934
dc.identifier.embargoNO
dc.identifier.filenameinventorynoIR03677
dc.identifier.issn1582-1838
dc.identifier.quartileN/A
dc.identifier.scopus2-s2.0-85129664122
dc.identifier.urihttps://hdl.handle.net/20.500.14288/4031
dc.identifier.wos792580300001
dc.keywordsCTRP9
dc.keywordsIschaemia/reperfusion injury
dc.keywordsSignalling pathways
dc.keywordsTherapeutic target
dc.language.isoeng
dc.publisherWiley
dc.relation.grantnoNA
dc.relation.ispartofJournal of Cellular and Molecular Medicine
dc.relation.urihttp://cdm21054.contentdm.oclc.org/cdm/ref/collection/IR/id/10539
dc.subjectCell biology
dc.subjectResearch and experimental medicine
dc.titlePutative therapeutic impacts of cardiac CTRP9 in ischaemia/reperfusion injury
dc.typeReview
dspace.entity.typePublication
local.contributor.kuauthorRajabi, Hadi
local.publication.orgunit1GRADUATE SCHOOL OF HEALTH SCIENCES
local.publication.orgunit1Research Center
local.publication.orgunit2KUTTAM (Koç University Research Center for Translational Medicine)
local.publication.orgunit2Graduate School of Health Sciences
relation.isOrgUnitOfPublication91bbe15d-017f-446b-b102-ce755523d939
relation.isOrgUnitOfPublication2f870f28-12c9-4b28-9465-b91a69c1d48c
relation.isOrgUnitOfPublication.latestForDiscovery91bbe15d-017f-446b-b102-ce755523d939
relation.isParentOrgUnitOfPublication4c75e0a5-ca7f-4443-bd78-1b473d4f6743
relation.isParentOrgUnitOfPublicationd437580f-9309-4ecb-864a-4af58309d287
relation.isParentOrgUnitOfPublication.latestForDiscovery4c75e0a5-ca7f-4443-bd78-1b473d4f6743

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
10539.pdf
Size:
2.1 MB
Format:
Adobe Portable Document Format
Download

Collections

Publications with Fulltext